Handelsbanken Fonder Ab Bluebird Bio, Inc. Transaction History

Handelsbanken Fonder Ab

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$11.24 - $21.0 $93,629 - $174,930	-8,330 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$18.04 - $22.09 $75,768 - $92,778	-4,200 Reduced 33.52%	8,330 $266,000
Q3 2020 Nov 13, 2020	BUY	$34.44 - $43.75 $68,880 - $87,500	2,000 Added 18.99%	12,530 $676,000
Q2 2020 Aug 13, 2020	BUY	$27.12 - $45.97 $285,573 - $484,064	10,530 New	10,530 $643,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.